The Female Health Company Receives Orders for 25 Million FC2 from Brazil
7:30 AM ET 1/26/15 | PR Newswire
The Female Health Company (NASDAQ-CM: FHCO) today announced that, its exclusive distributor in Brazil, Semina Industria e Comercio Ltda has placed orders for 25 million FC2 Female Condoms.
photos.prnewswire.com
"These orders have been received in fulfillment of the Brazilian Ministry of Health tender awarded in 2014," noted Karen King, President and Chief Executive Officer of The Female Health Company. "By mid-December, we had already produced and shipped over 5 million units and we anticipate the majority of the units under these orders to ship in FHC's fiscal Q2, between January and March 2015."
"Once again, I would like to point to the global leadership Brazil has demonstrated with its exemplary HIV/AIDS prevention program and a strong commitment to empowering women to take control of their health and wellness. We are pleased to be contributing to their successful program through our training and education efforts in country and through supply of FC2, a critical tool for women in protecting against sexually-transmitted diseases and unwanted pregnancies."
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom(R) (FC2). Since the Company began distributing FC2 in 2007, it has been shipped to 144 countries. The Company owns certain worldwide rights to the FC2 Female Condom(R), including patents that have been issued in a number of countries around the world. The patents cover the key aspects of FC2, including its overall design and manufacturing process. The FC2 Female Condom(R) is the only currently available female-controlled product approved by FDA that offers dual protection against sexually transmitted infections, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995: |
